| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Mental Health and Mental Retardation Authority of Harris County is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
ShapeUp is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Providence, RI. To find more information about ShapeUp, please visit www.shapeup.com
Executive Health Resources is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Newtown Square, PA. To find more information about Executive Health Resources, please visit www.ehrdocs.com
Actelion Pharmaceuticals is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in South San Francisco, CA. To find more information about Actelion Pharmaceuticals, please visit www.actelion.com